F. J. Cleton - Concepedia

Author

F. J. Cleton

Also Known As

F Cleton, F J CLETON, F J Cleton, F. Cleton, F. J Cleton, F. J. CLETON, F. J. Cleton, F.J Cleton, F.J. Cleton, FRANS CLETON

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Leiden University The Netherlands Cancer Institute The Honourable Society of Lincoln's Inn Guy's Hospital Leiden University Medical Center

About

F. J. Cleton is an author at Leiden University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	2K
2	Health Sciences	2	2	289
3	Public Health	2	2	53
4	Language Studies	1	1	18
5	Nursing	1	1	93

F. J. Cleton

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study Nir I. Weijl, T.J Elsendoorn, Eef G.W.M. Lentjes, European Journal of Cancer OncologyCisplatin-based ChemotherapyMedicinePharmacologyAntioxidant Micronutrients	2004	254
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Nir I. Weijl, G. D. Hopman, A. Wipkink-Bakker, Annals of Oncology MedicinePharmacologyPathologyCisplatin Combination ChemotherapyPlasma Antioxidants	1998	214
REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT A.Th. van Holten-Verzantvoort, O. L. M. Bijvoet, J. Hermans, The Lancet Bone DiseaseBreast OncologyBone HealthMedicineBreast Cancer	1987	203
Palliative pamidronate treatment in patients with bone metastases from breast cancer. A.Th. van Holten-Verzantvoort, Hidde M. Kroon, O. L. M. Bijvoet, Journal of Clinical Oncology	1993	197
IRON ABSORPTION. IV. THE ABSORPTION OF HEMOGLOBIN IRON* Adam Turnbull, F. J. Cleton, Clement A. Finch Journal of Clinical Investigation Iron MetabolismIron DeficiencyHemin IronRedox BiologyOxidative Stress	1962	196
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2 Peter Palmer, J. Vinke, Thierry Philip, Annals of Oncology Prognostic FactorsUrologyGenitourinary CancerMedicineImmune Checkpoint Inhibitor	1992	156
Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment. Nir I. Weijl, D van der Harst, Anneke Brand, Journal of Clinical Oncology	1993	99
PLASMA-PROLACTIN IN HUMAN BREAST CANCER H. G. Kwa, E Engelsman, M. De Jong‐Bakker, The Lancet Breast OncologyMedicinePathologyBreast CancerOncology	1974	94
The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer Angelique T. M. van Holten-Verzantvoort, Aeilko H. Zwinderman, Neil K. Aaronson, European Journal of Cancer and Clinical Oncology NursingPalliative CareQuality Of LifeAdvanced Breast CancerBreast Oncology	1991	93
Oestrogen Receptor in Human Breast Cancer Tissue and Response to Endocrine Therapy E Engelsman, J.-P. Persijn, C. B. Korsten, BMJ Oestrogen ReceptorBreast OncologyOncologyMedicineHormonal Receptor	1973	79

Page 1